Structure-guided peptide engineering of a positive allosteric modulator targeting the outer pore of TRPV1 for long-lasting analgesia

Nat Commun. 2023 Jan 3;14(1):4. doi: 10.1038/s41467-022-34817-1.

Abstract

Transient receptor potential vanilloid 1 (TRPV1) ion channel is a classic analgesic target, but antagonists of TRPV1 failed in clinical trials due to their side effects like hyperthermia. Here we rationally engineer a peptide s-RhTx as a positive allosteric modulator (PAM) of TRPV1. Patch-clamp recordings demonstrate s-RhTx selectively potentiated TRPV1 activation. s-RhTx also slows down capsaicin-induced desensitization of TRPV1 in the presence of calcium to cause more calcium influx in TRPV1-expressing cells. In addition, our thermodynamic mutant cycle analysis shows that E652 in TRPV1 outer pore specifically interacts with R12 and K22 in s-RhTx. Furthermore, we demonstrate in vivo that s-RhTx exhibits long-lasting analgesic effects in noxious heat hyperalgesia and CFA-induced chronic inflammatory pain by promoting the reversible degeneration of intra-epidermal nerve fiber (IENF) expressing TRPV1 channels in mice, while their body temperature remains unaffected. Our results suggest s-RhTx is an analgesic agent as a PAM of TRPV1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesia*
  • Analgesics / pharmacology
  • Analgesics / therapeutic use
  • Animals
  • Calcium
  • Capsaicin / pharmacology
  • Mice
  • Pain / drug therapy
  • Peptides / pharmacology
  • Peptides / therapeutic use
  • TRPV Cation Channels / genetics
  • Transient Receptor Potential Channels*

Substances

  • Calcium
  • TRPV Cation Channels
  • Analgesics
  • Capsaicin
  • Transient Receptor Potential Channels
  • Peptides
  • TRPV1 protein, mouse